HealthyDirect · GrowthFit for a long SIP
HSBC India Export Opportunities Fund
HSBC Mutual FundEquity Schemes - Thematic Fund2.1 years
The scheme seeks to generate long-term capital growth from an actively managed portfolio of equity and equity related securities of companies engaged in or expected to benefit from export of goods or services. There is no assurance that the objective of the scheme will be realised and the scheme does not assure or guarantee any returns.
- NAV
- 11.5884
- 29 Oct 2026
- 1Y
- +14.2%
- Trailing CAGR
- Upside capture
- +129%
- Vs NIFTY 500 TRI
- Downside capture
- +74%
- Lower is better
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 28 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 65% of rolling 1-year windows.
Buy checklist
History depth
Fail
2.1 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.04% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -20.5%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Mayank Chaturvedi · 1.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 36.3% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 21%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+14.2%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+7.3%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+20.6%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +7.3%
- Calendar-day CAGR
- Excess 1Y
- +18.8%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Official benchmark
Date-aligned against NIFTY 500 TRI. Capture ratios use common month-end observations through 29 Oct 2026.
- 1Y excess
- +22.2%
- Fund minus TRI
- 3Y excess
- n/a
- Fund minus TRI
- Upside capture
- +129%
- Benchmark-up months
- Downside capture
- +74%
- Lower is better
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -20.5%
- Worst peak-to-trough
- Current
- -5.8%
- Below last peak
- Current spell
- 58 days
- Days below latest peak
- Time below peak
- +91%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 28 days
- 16 recovered episodes
- Longest recovery
- 395 days
- Trough to prior peak
11 Dec 2024 – 7 May 2026
Trough 7 Apr 2025 · recovered in 395 days
-20.5%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.3%
16 Oct 2024 – 2 Dec 2024
Trough 18 Nov 2024 · recovered in 14 days
-4.6%
8 May 2026 – 25 May 2026
Trough 12 May 2026 · recovered in 13 days
-3.8%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
54
Vs category
100
Consistency
65
Risk-adjusted
33
Drawdown
49
Mean
60
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 65% of rolling 1-year windows.
Portfolio
30 Sept 2026 · 52 holdings · top 10 are 36.3%.
- Top 5
- 22.1%
- Top 10
- 36.3%
- Largest holding
- 6.6%
- Effective holdings
- 39.4
Avalon Technologies Ltd.
Industrials
6.6%
Pearl Global Industries Ltd
Consumer Discretionary
4.9%
Divi's Laboratories Ltd
Healthcare
3.9%
Hindalco Industries Ltd
Materials
3.4%
Reliance Industries Ltd
Energy & Utilities
3.3%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Mahindra Manulife Business Cycle Fund
Mahindra Manulife Mutual Fund
- 1Y
- -4.5%
- 3Y
- +15.8%
- Vol
- 15.7%
- Max DD
- -21.4%
- Sharpe
- 0.55
- 3Y win
- +100%
- Lower volatility
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
DSP Business Cycle Fund
DSP Mutual Fund
- 1Y
- -4.5%
- 3Y
- n/a
- Vol
- 13.7%
- Max DD
- -14.8%
- Sharpe
- -0.37
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
Nippon India Active Momentum Fund
Nippon India Mutual Fund
- 1Y
- +1.6%
- 3Y
- n/a
- Vol
- 15.2%
- Max DD
- -12.6%
- Sharpe
- 0.53
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
WhiteOak Capital Special Opportunities Fund
WhiteOak Capital Mutual Fund
- 1Y
- +6.4%
- 3Y
- n/a
- Vol
- 14.7%
- Max DD
- -17.0%
- Sharpe
- 0.64
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
HDFC Defence Fund
HDFC Mutual Fund
- 1Y
- +14.9%
- 3Y
- +35.1%
- Vol
- 25.0%
- Max DD
- -34.5%
- Sharpe
- 1.17
- 3Y win
- +100%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown